Immunotherapy Clinical Trials

301 clinical trials for Immunotherapy across international registries, including 107 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Investigating Real-Time Immunotherapy Symptoms Study — RECRUITING · NA
• The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer — RECRUITING · PHASE2
• Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study — RECRUITING · NA
• Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) — RECRUITING
• Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy — RECRUITING
• Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event — RECRUITING · NA
• A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial) — RECRUITING · PHASE2
• EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER — RECRUITING · NA
• Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer — RECRUITING
• Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS) — RECRUITING · PHASE1
• Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer — RECRUITING · PHASE2
• A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer — RECRUITING · PHASE3
• BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases — RECRUITING · PHASE2
• Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment — RECRUITING
• Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy — RECRUITING
• Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases — RECRUITING · PHASE2
• IMMUNO-FIT Observational Study — RECRUITING
• A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer — RECRUITING · PHASE2
• CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC — RECRUITING · PHASE3
• Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer — RECRUITING · PHASE2
• Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation — RECRUITING · PHASE4
• Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy — RECRUITING · PHASE2
• Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer — RECRUITING · PHASE2
• To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study) — RECRUITING
• Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy — RECRUITING
• Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores — RECRUITING
• Neoadjuvant Treatment Modalities in Esophageal Cancer — RECRUITING · PHASE3
• Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer — RECRUITING · PHASE3
• TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC — RECRUITING · PHASE3
• Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer — RECRUITING · PHASE2
• Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC) — RECRUITING · PHASE2
• The Difference of microRNA and Circulating Tumor Cells in Blood Among Cancer Patients With Immunotherapy — RECRUITING
• VSV-02 Compassionate Use in Advanced Solid Tumors — RECRUITING · PHASE1
• Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma — RECRUITING · PHASE1
• A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC — RECRUITING · PHASE1
• Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer — RECRUITING · NA
• The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial — RECRUITING · PHASE2
• SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC — RECRUITING · PHASE2
• Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer — RECRUITING
• Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05) — RECRUITING · PHASE2
• Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer — RECRUITING · PHASE2
• Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer — RECRUITING · PHASE2
• Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA) — RECRUITING · PHASE2
• Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals — RECRUITING
• Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC — RECRUITING · PHASE2
• Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer — RECRUITING · PHASE3
• The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment — RECRUITING
• A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies — RECRUITING
• Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations. — RECRUITING · PHASE4
• SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy — RECRUITING · PHASE2

Refine this search